Prosecutors said that the hospital pharmacy failed to obtain the treating physician’s signature on the order to establish medical necessity, failed to confirm refills were needed and didn’t document that the medications were delivered.
“Healthcare providers will be held accountable when they knowingly submit false claims for prescription drugs that do not meet requirements to establish medical necessity,” said Jody Hunt, assistant attorney general in the Justice Department’s civil division.
The settlement also resolves allegations that the hospital violated the federal Anti-Kickback Statute by submitting claims to Medicare that resulted in improper payments to Medicare beneficiaries in the form of free supplies for blood glucose testing and waiver of copays and deductibles for insulin.
The whistleblower allegations were originally brought by Robert Stone, a former pharmacist at the hospital.
More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.